The University of Queensland in Australia has reported positive findings from early preclinical testing of its Covid-19 vaccine candidate.
According to the data, the vaccine candidate raised significant levels of antibodies to neutralise the virus. The University of Queensland received funding and support from the Coalition for Epidemic Preparedness Innovation (CEPI) to develop a Covid-19 vaccine.
The university collaborated with the Peter Doherty Institute for Infection and Immunity to study the vaccine and its immune response.
University of Melbourne professor Kanta Subbarao, part of the Doherty Institute, analysed samples provided by the UQ team. The preclinical analysis revealed high levels of antibodies that could neutralise